Companies / Guardant Health, Inc.
Guardant Health, Inc.
Nasdaq: GHCIK 1576280PALO ALTO, CA
Insider flow · last 90 daysNet sells $939.1K
Financials · FY2025
Ownership
134.2M shares outstanding · as of Jul 24, 2026
Ownership
| Insiders | 6.50% | 8,726,600 |
| Institutions | 96.61% | 129,647,251 |
| Public float | 0.00% | 0 |
Reported holdings exceed shares outstanding — public float shown as 0; some positions may overlap or lag.
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 15
View all →| Insider | % of shares | Shares |
|---|---|---|
Eltoukhy HelmyCEOCo-Chief Executive Officer · Director | 3.10% | 4,157,630 |
Talasaz AmirAliCEOCo-Chief Executive Officer · Director | 3.09% | 4,141,946 |
Chudova DaryaChief Technology Officer | 0.06% | 73,890 |
Eagle CraigChief Medical Officer | 0.05% | 66,380 |
Saia John G.Chief Legal Officer | 0.04% | 56,903 |
Freeman ChrisChief Commercial Officer | 0.04% | 53,571 |
Kalia KumudChief Information Officer | 0.03% | 44,297 |
Bell Michael BrianChief Financial Officer | 0.03% | 43,601 |
Monroe Terilyn J.Chief People Officer | 0.02% | 20,990 |
Potter Myrtle SDirector | 0.02% | 20,971 |
Institutional holders 504
View all →| Holder | Value | % of shares |
|---|---|---|
| $1.24B | 9.06% | |
| $1.14B | 5.68% | |
| $542.97M | 3.96% | |
| $390.68M | 3.15% | |
| $360.42M | 2.63% | |
| $356.46M | 2.88% | |
| $343.35M | 2.50% | |
| $339.62M | 1.69% | |
| $324.17M | 2.61% | |
| $285.99M | 2.09% |
Activity
Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q2 2026 as of | BlackRock, Inc. 13F manager | Trim | Common stock | $-554.33M | -3.7M -32.65% | 7,622,935 5.68% of shares | high |
| Q1 2026 as of | Two Sigma Investments, LP 13F manager | Add | Common stock | $190.06M | +2.1M +94.74% | 4,229,531 3.15% of shares | high |
| Q1 2026 as of | Norges Bank 13F manager | Exit | Common stock | $-128.50M | -1.3M -100.00% | 0 | high |
| Q1 2026 as of | Baillie Gifford & Co 13F manager | Trim | Common stock | $-95.23M | -1.0M -21.08% | 3,859,046 2.88% of shares | high |
| Q2 2026 as of | State Street Corporation 13F manager | Trim | Common stock | $-79.85M | -532K -19.04% | 2,263,504 1.69% of shares | high |
| Q1 2026 as of | Westfield Capital Management Company, L.P. 13F manager | Add | Common stock | $76.05M | +823K +152.70% | 1,362,539 1.02% of shares | high |
| Q1 2026 as of | Balyasny Asset Management L.P. 13F manager | Exit | Common stock | $-51.64M | -506K -100.00% | 0 | high |
| Q1 2026 as of | Orbimed Advisors LLC 13F manager | New | Common stock | $40.20M | +435K | 435,200 0.32% of shares | medium |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Vanguard Group Inc | Passive13G/A | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| GH | — | 40131M109 |